Journal of Kerman University of Medical Sciences

Evaluation of rs37464444 Polymorphism of miR-499 Gene in Patients with Colon Cancer Compared with Healthy Subjects

Document Type : Original Article

Authors

Behjat Kalantari Khandani 1
Sara Shafieipour 2
Amir Mobasserfar 3
Mohammad Javad Zahedi 4
Mohammad Hashemi 5
Mohammad Mahdi Hayatbakhsh Abbasi 6
Sodaif Darvish Moghadam 6

1 Assistant Professor, Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

2 Assistant Professor, Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Assistant Professor, Department of Internal Medicine, Rafsanjan University of Medical Scienses, Rafsanjan, Iran

4 Professor, Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran

5 Professor, Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

6 Professor, Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

https://doi.org/10.22062/jkmu.2020.90639
Abstract
Background: Single nucleotide polymorphisms (SNPs) have been introduced as a new genomic source for cancer. Therefore, it was decided to conduct a study to evaluate the rs3746444 polymorphism of miR-499 in patients with colon cancer in comparison with healthy subjects.
Methods: This case-control study was conducted to investigate rs3746444 polymorphism of miR-499 in blood samples of case and control groups. Patients with a confirmed diagnosis of cancer based on pathologic report were enrolled in the study as the case group and compared with healthy subjects. The level of significance was considered at p < 0.05.
Result: The mean of DNA count in samples was 63.17± 23.51 that was significantly higher in the case group. The rs3746444 polymorphism of miR-499 was significantly higher in patients with cancer compared to the healthy subjects (P < 0.05).
Conclusion: In this study, rs3746444 polymorphism of miR-499 was significantly higher in patients with colon cancer, which indicated that people with this polymorphism had a higher risk for malignancy.

Keywords

Rs3746444 Polymorphism miR
499 Colon Cancer
  1. Karimi Zarchi AA, Saadat AR, Jalalian HR, Esmaeili M. Epidemiology and survival analysis of colorectal cancer and its related factors. Kowsar Medical Journal 2011; 15(4):239-43. [In Persian].
  2. Akhoond MR, Kazemnejad A, Hajizadeh E, Ganbary Motlagh A, Zali MR. Comparison of influential factors affecting survival of patients with colon and rectum cancer using competing risks model. Koomesh 2011; 12(2):119-28. [In Persian].
  3. Giovannucci E. Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt) 2003; 12(2):173-82.
  4. Alshatwi AA, Shafi G, Hasan TN, Ahmed Syed N, Al-Hazzani AA, Alsaif MA, et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One 2012; 7(2):e30049.
  5. Koga Y, Yamazaki N, Matsumura Y. New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA. Expert Rev Mol Diagn 2014; 14(1):107-20.
  6. Lee RC, Feinbaum RL, Ambros V. The C. elegansheterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-54.
  7. Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP. Vertebrate microRNA genes. Science 2003; 299(5612):1540.
  8. Akkiz H, Bayram S, Bekar A, Akgollu E, Uskudar O. Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case–control study. Asian Pac J Cancer Prev 2011; 12(11):3107-12.
  9. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-targetrecognition. PloS Biol 2005; 3(3):e85.
  10.  Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003; 113(6):673-6.
  11.  Davis MP, Abreu-Goodger C, van Dongen S, Lu D, Tate PH, Bartonicek N, et al. Large-scale identification of microRNA targets in murine dgcr8-deficient embryonic stem cell lines. PLoS One 2012; 7(8):e41762.
  12.  Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998; 280(5366):1077-82.
  13.  Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 2007; 104(9):3300-5.
  14.  Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008; 118(7):2600-8.
  15.  Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, et al. Association study of common genetic variants in pre-microRNAs in patients withulcerative colitis. J Clin Immunol 2011; 31(1):69-73.
  16.  Liu Z, Li G, Wei S, Niu J, El‐Naggar AK, Sturgis EM, et al. Genetic variants in selected pre- icroRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010; 116(20):4753-60.
  17.  Min KT, Kim JW, Jeon YJ, Jang MJ, Chong SY, Oh D, et al. Association of the miR‐146aC> G, 149C> T, 196a2C> T, and 499A> G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog 2012; 51(Suppl 1):E65-73.
  18.  Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28(7):2167-74.
  19.  Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H, et al. Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer. Am J Transl Res 2014; 6(4):391-401.
  20.  Pu JY, Dong W, Zhang L, Liang WB, Yang Y, Lv ML. No association between single nucleotide polymorphisms in pre-mirnas and the risk of gastric cancer in Chinese population. Iran J Basic Med Sci 2014; 17(2):128-33.
  21.  Hasani SS, Hashemi M, Eskandari-Nasab E, Naderi M, Omrani M, Sheybani-Nasab M. A functional polymorphism in the miR-146a gene is associated with the risk of childhood acute lymphoblastic leukemia: a preliminary report. Tumour Biol 2014; 35(1):219-25.
  22.  Omrani M, Hashemi M, Eskandari-Nasab E, Hasani SS, Mashhadi MA, Arbabi F, et al. hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med 2014; 8(2):259-67.
  23.  Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4(2):45-61.
  24. Yang W, Baohong Y, Xiubao R. Hsa-miR-499 polymorphism (rs3746444) and cancer risk: A meta-analysis of 17 case–control studies. Gene 509 2012; 267–272.
  25.  He B, Pan Y, Cho WC, Xu Y, Gu L, Nie Z, et al. The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PloS One 2012; 7(11):e49032.
  26.  Zhang YG, Shi JX, Song CH, Wang P, Dai LP, Zhang JY, et al. Association of mir-499 and mir-149 polymorphisms with cancer risk in the Chinese population: evidence from published studies. Asian Pac J Cancer Prev 2013; 14(4):2337-42.
  27.  Asadi M, Shanehbandi D, Zarintan A, Pedram N, Baradaran B, Zafari V, et al. TP53Gene Pro72Arg (rs1042522) single nucleotide polymorphism as not a risk factor for colorectal cancer in the Iranian Azari population. Asian Pac J Cancer Prev 2017; 18(12):3423-7.
  28.  Zhu ZZ, Wang AZ, Jia HR, Jin XX, He XL, Hou LF, et al. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population. Jpn J Clin Oncol 2007; 37(5):385-90.
  29.  Nikbahkt Dastjerdi M, Salehi M, Mohajeri MR, Morsali F, Mirmohammad Sadeghi H, Esfandiari E. Evidence for an association of TP53 codon 72 polymorphism with sporadic colorectal cancer risk in Isfahan. J Res Med Sci 2008; 13(6):317-23.
  30.  Du W, Ma XL, Zhao C, Liu T, Du YL, Kong WQ, et al. Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility. Asian Pac J Cancer Prev 2014; 15(2):1047-55.

Journal of Kerman University of Medical Sciences
Volume 27, Issue 3
May and June 2020
Pages 204-212

Home

Editorial Board

Guide for Authors

Submit Manuscript

Guide for Reviewers

Contact Us